Measuring oestradiol level and controlling it with an aromatase inhibitor may be the first opportunity to manage a potential cancer in the way cardiologists deal with heart disease by measuring cholesterol and using a statin to lower it when necessary. Here, CYP19A1 is linked to heart disorder.